UK Members 
US Members 
Specialty Pharma – new uses for existing drugs
The process of finding new uses outside the scope of the original medical indication for existing drugs is an area of Specialty Pharma that is growing steadily. With this approach, development risk is reduced because candidate drugs will have passed through several stages of clinical development and therefore have well-known safety and pharmacokinetic profiles. Shorter routes to the clinic are also possible because in vitro and in vivo screening, chemical optimization, toxicology, bulk manufacturing, formulation development and postmarketing surveillance will in many cases have been completed. Together these factors enable several years, substantial risks and costs to be removed from the pathway to the new market. Consequently, ‘repositioning’ of existing drugs can offer a better risk-to-reward ratio by comparison with other drug development strategies. Click here to read more.
Learn why www.off-label.com is a new model for R&D. Find out how to use this website in your search for new pipeline candidates. Click here to read more